• 1
    Littenberg B, Garber AM, Sox HC Jr. Screening for hypertension. Ann Intern Med 1990; 112: 192202.
  • 2
    Wynder EL, Field F, Haley NJ. Population screening for cholesterol determination. JAMA 1986; 256: 28392842.
  • 3
    Eddy DM. Screening for breast cancer. Ann Intern Med 1989; 111: 389399.
  • 4
    Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39: 27722782.
  • 5
    UK trial of early detection of breast cancer group. First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 1988; 2: 411416.
  • 6
    Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med 1991; 325: 3741.
  • 7
    American College of Physicians. In: Eddy DM, ed. Common screening tests. Philadelphia, PA: 1991.
  • 8
    Bradbear RA, Robinson WN, Cooksley WGE, Halliday JW, Harris OD, Powell LW. Are the causes and presentation of chronic hepatitis changing? an analysis of 104 cases over 15 years. Q J Med 1984; 53: 279288.
  • 9
    Tanner AR, Dellipani AW. Chronic active hepatitis: a sixteen year survey at a distinct general hospital. Postgrad Med J 1989; 65: 725728.
  • 10
    Hall CB, Easton JG, Granoff DM, Gromisch DS, Halsey NA, Kohl S, Marcuse EK, et al. Committee on infectious diseases, American Academy of Pediatrics, universal hepatitis B immunization. Pediatrics 1992; 89: 795800.
  • 11
    Centers for Disease Control. Hepatitis B virus, a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1991; 40: 125.
  • 12
    Bortolotti F, Tagger A, Cardrobbi P, Crivellaro C, Pregliasco F, Ribero ML, Alberti A. Antibodies to hepatitis C virus in community acquired non A, non B hepatitis. J Hepatol 1991; 12: 17680.
  • 13
    Alter MJ. Epidemiology of community acquired hepatitis C. In: HollingerFB, LemonSM, MargolisH, eds. Viral Hepatitis and liver disease. Baltimore: Williams and Wilkins, 1991: 410413.
  • 14
    Alter MJ, Coleman PJ, Alexander J, Kramer E, Miller JK, Mandel E, Hadler SC, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989; 262: 12011205.
  • 15
    Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, Hoofnagle JH. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990; 112: 544545.
  • 16
    Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 22312235.
  • 17
    Wisdom GB. Enzyme immunoassay. Clin Chem 1976; 22: 12431255.
  • 18
    Kennedy RC, Loniacu-Matiu I, Alder-Storthz K, Henkel RD, Sanchez Y, Droosman GR. Characterization of anti-hepatitis B surface antigen monoclonal antibodies. Intervirology 1983; 19: 176180.
  • 19
    Vallari DS, Jett BW, Alter HJ, Mimmis LT, Holzman R, Shih JW. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol 1992; 30: 552556.
  • 20
    DiBiSceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alpha therapy for chronic hepatitis, a randomized double blind placebo controlled trial. N Engl J Med 1989; 321: 15061510.
  • 21
    Marcellin P, Boyer N, Giostra E, Degott C, Degos F, Coppere H, Cales P, et al. Better efficacy of high dose versus low dose recombinant interferon alpha 2b treatment in chronic NANB hepatitis [Abstract]. Hepatology 1989; 10: 646A.
  • 22
    Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta analysis. Ann Intern Med 1993; 119: 312323.
  • 23
    Alter MJ, Sampliner RE. Hepatitis C: and miles to go before we sleep. N Engl J Med 1989; 321: 15381540.
  • 24
    Dienstag JL. Non A, non B hepatitis, I: recognition, epidemiology and clinical features. Gastroenterology 1983; 85: 439462.
  • 25
    Koretz RL, Stone O, Mousa M, Gitnick GL. Non A, non B post transfusion hepatitis-a decade later. Gastroenterology 1985; 88: 12511254.
  • 26
    Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransfer-ases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90: 12501257.
  • 27
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1993; 327: 18991905.
  • 28
    Achkar E, Carey WD. Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients. Ann Int Med 1988; 109: 880883.
  • 29
    Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening co-lonscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 6467.
  • 30
    Centers for Disease Control and Prevention. Public Health Focus: mam-mography. MMWR. 1992; 41: 454459.
  • 31
    Centers for Disease Control and Prevention. Results from the National Breast and Cervical Cancer Early Detection Program. MMWR. 1994; 43: 530534.
  • 32
    Giatto S, Bonardi R, Mazotta A, Lombardi C, Zappa M. Clinico-echographic screening in the early diagnosis of prostatic cancer, preliminary results of a feasibility study of randomized trial. Radiol Med 1993; 85: 430433.
  • 33
    Gilbertson VA, Nelma JM. The prevention of invasive cancer of the rectum. Cancer 1978; 41: 11371139.
  • 34
    Hertz REL, Deddish MR, Day E. Value of periodic examinations in detecting cancer of the colon and rectum. Postgrad Med J 1960; 27: 290294.
  • 35
    American Cancer Society. Appendix B. CA-a cancer journal for clinicians. 1980; 30: 234236.
  • 36
    Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer, the Health Insurance Plan Project and its sequalae, 1963–1986. Baltimore: The Johns Hopkins University Press; 1988: 112.
  • 37
    Task force on cytological screening, cervical cancer screening programs. Canadian Med Assoc J 1976; 114: 10031033.
  • 38
    Morrison AS. Public health value of using epidemiologic information to identify high risk groups for bladder cancer screening. Semin Oncol 1979; 6: 184188.
  • 39
    Morrison AS, Cole P. Epidemiology of urologic cancer. In: JavadpourN, ed. Principles and management of urologic cancer. Baltimore: Williams and Wilkins, 1978: 1209.
  • 40
    Rampen F, Berretty P, Van Huystee B, Kiemeney L, Nijs C. Lack of selective attendance of participants at skin cancer/melanoma screening clinics. J Am Acad Dermatol 1993; 29: 423427.
  • 41
    Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T. Hepatitis C virus infection in medical personnel after needle-stick accident. Hepatology 1992; 16: 11091114.
  • 42
    Kiyosawa K, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, Purcell RH, et al. Hepatitis C in hospital employees with needle stick injuries. Ann Int Med 1991; 115: 367369.
  • 43
    Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F, Frosner G, et al. Sporadic non A, non B hepatitis, frequency and epidemiology in an urban U.S. population. J Infect Dis 1982; 145: 886893.
  • 44
    Hernandez ME, Bruguera M, Puyuelo T, Barrera JM, Sanchez Tapias J, Rodes J. Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel. J Hepatol 1992; 16: 5658.
  • 45
    Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993; 21: 196200.
  • 46
    Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC. Viral hepatitis in health care personnel at the Johns Hopkins Hospital. Arch Intern Med 1993; 153: 17051712.
  • 47
    Kotwal GJ, Rustgi VK, Baroudy BM. Detection of hepatitis C virus-specific antigens in semen from non A, non B hepatitis patients. Dig Dis Sci 1992; 37: 641644.
  • 48
    Wang JT, Wang TH, Lin JT, Sheu JC, Chen DS. Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis C infection (letter). Lancet 1991; 337: 48.
  • 49
    Akahane Y, Kojima M, Sugai Y, Sakamoto M, Miyazaki Y, Tanaka T, Tsuda F, et al. Hepatitis C virus infection in spouses of patients with Type C chronic liver disease. Ann Intern Med 1994; 120: 748752.
  • 50
    Centers for Disease Control. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1990; 39: 25.
  • 51
    Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990; 263: 12181222.
  • 52
    Koretz RL, Abbey H, Coleman E, Gitnick G. Non A, non B post transfusion hepatitis, looking back in the second decade. Ann Intern Med 1993; 119: 110115.
  • 53
    Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240243.
  • 54
    Resnick RH, Koff R. Hepatitis C related hepatocellular carcinoma: prevalence and significance. Arch Intern Med 1993; 153: 16721677.
  • 55
    Seeff L, Buskell-Bales Z, Wright EC. Long-term mortality after transfusion associated non A, non B hepatitis. N Engl J Med 1992; 327: 19061911.